Preventative maintenance agreement-nextseq sequencing instrument(serial NS500253)
Ended Purchase Order Awarded Last action
- Contract number
- HHSF223201610090P
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $88,966
Award facts
- Opportunity
-
- FDASOL1160561 Solicitation number
- Maintenance Agreement for an Illumina NextSeq 500 next-generation DNA Sequencer (serial number NS500253) Award Notice · Posted Feb 12, 2016
- Contract value 100% obligated
- $88,966.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Exercise an Option | $30,826 | |
| Exercise an Option | $29,640 | |
| Other Administrative Action | $0 | |
| Original award | $28,500 |
About this award
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing instruments and related technologies. The contract, valued at $88,966.00, is for preventative maintenance services on a NextSeq sequencing instrument (serial number NS500253) used by the FDA. The contract does not have a set-aside designation. Illumina is the prime contractor and there is no information provided about any subcontractors.
The FDA has awarded Illumina numerous prime federal contracts and grants, primarily for the procurement of advanced genomic sequencing platforms, reagents, and support services across various scientific research, healthcare, and diagnostic applications. Illumina also holds Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs for the flexible acquisition of Illumina's products and services at multiple VA facilities.
Quick answers
Who was awarded contract HHSF223201610090P?
HHSF223201610090P was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on April 19, 2016.
How much is contract HHSF223201610090P worth?
The government has obligated $88,966 on HHSF223201610090P.
Was contract HHSF223201610090P competed?
The extent of competition for HHSF223201610090P was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award